The effects of the Pro12Ala polymorphism of the PPARγ-2 gene on lipid metabolism interact with body size at birth

Clinical Genetics

Volumn 64, Issue 4, 2003, Pages 366-370

  Eriksson, Johan ^a   Lindi, V ^b   Uusitupa, M ^b   Forsen T ^a,c   Laakso, M ^d   Osmond, C ^e   Barker, D ^e  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Birth weight; Developmental plasticity; Dyslipidemia; Gene environment interaction; PPAR 2 gene

Indexed keywords

ALANINE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROLINE;

ADIPOCYTE; AGED; ALLELE; ARTICLE; BIRTH; BIRTH WEIGHT; BODY SIZE; CELL DIFFERENTIATION; CONTROLLED STUDY; DEVELOPMENT; DNA POLYMORPHISM; DYSLIPIDEMIA; FEMALE; GENE INTERACTION; GENETIC TRAIT; GENOTYPE; GLUCOSE METABOLISM; HUMAN; INSULIN METABOLISM; INSULIN RESISTANCE; LIPID METABOLISM; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PLASTICITY; PRIORITY JOURNAL; UTERUS;

AGED; ALLELES; BIRTH WEIGHT; COHORT STUDIES; FINLAND; HUMANS; LIPID METABOLISM, INBORN ERRORS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; POLYMORPHISM, GENETIC; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS; TRIGLYCERIDES;

EID: 0141886852     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2003.00150.x     Document Type: Article

References (32)

1. West-Eberhard MJ. Phenotypic plasticity and the origins of diversity. Annu Rev Ecol Syst 1989: 20: 249-278.
2. Barker DJP, Osmond C, Winter PD, Margetts B, Simmonds SJ. Weight in infancy and death from ischaemic heart disease. Lancet 1989: 2: 577-580.
3. Hales CN, Barker DJP, Clark PMS et al. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 1991: 303: 1019-1022.
4. Forsen T, Eriksson J, Tuomilehto J, Reunanen A, Osmond C, Barker D. The fetal and childhood growth of persons who develop type 2 diabetes. Ann Intern Med 2000: 133: 176-182.
5. Eriksson JG, Forsen T, Tuomilehto J, Winter PD, Osmond C, Barker DJP. Catch-up growth in childhood and death from coronary heart disease: longitudinal study. BMJ 1999: 318: 427-431.
6. Barker DJP. The fetal origins of adult disease. Proc R Soc Lond B 1995: 262: 37-43.
7. Eriksson JG, Lindi V, Uusitupa M et al. The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ 2 gene on insulin sensitivity and insulin metabolism interact with size at birth. Diabetes 2002: 51: 2321-2324.
8. Debril M-B, Renaud J-P, Fajas L, Auwerx J. The pleiotropic functions of peroxisome proliferator-activated receptor-γ. J Mol Med 2001: 79: 30-47.
9. Auwerx J. PPARγ, the ultimate thrifty gene. Diabetologia 1999: 42: 1033-1049.
10. Deeb SS, Fajas L, Nemoto M et al. A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 1998: 20: 284-287.
11. Valve R, Sivenius K, Miettinen R et al. Two polymorphisms in the peroxisome proliferator-activated receptor-γ gene are associated with severe overweight among obese women. J Clin Endocrinol Metab 1999: 84: 3708-3712.
12. Meirhaeghe A, Fajas L, Helbecque N et al. Impact of the peroxisome proliferator activated receptor γ 2 Pro12Ala polymorphism on adiposity, lipids, and non-insulin-dependent diabetes mellitus. Int J Obes 2000: 24: 195-199.
13. Sunvold H, Lien S. Identification of a novel peroxisome proliferator-activated receptor (PPAR)-γ promoter in man and transactivation by the nuclear receptor RORα1. Biochem Biophys Res Commun 2001: 287: 383-390.
14. Yen C-J, Beamer BA, Negri C et al. Molecular scanning of the human peroxisome proliferator activated receptor γ (hPPARγ) gene in diabetic Caucasians: Identification of a Pro12Ala PPARγ2 missense mutation. Biochem Biophys Res Commun 1997: 241: 270-274.
15. Vigouroux C, Fajas L, Khallouf E et al. Human peroxisome proliferator-activated receptor-γ2. Genetic mapping, identification of a variant in the coding sequence, and exclusion as the gene responsible for lipoatrophic diabetes. Diabetes 1998: 47: 490-492.
16. Altshuler D, Hirschhorn JN, Klannemark M et al. The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000: 26: 76-80.
17. Hegele RA, Cao H, Harris SB, Zinman B, Hanley AJG, Anderson CM. Peroxisome proliferator-activated receptor-γ2 P12A and type 2 diabetes in Canadian Oji-Cree. J Clin Endocrinol Metab 2000: 85: 2014-2019.
18. Evans D, de Heer J, Hagemann C et al. Association between the P12A and c1431t polymorphisms in the peroxisome proliferator activated receptor gamma (PPARγ) gene and type 2 diabetes. Exp Clin Endocrinol Diabetes 2001: 109: 151-154.
19. Hara K, Okada T, Tobe K et al. The Pro12Ala polymorphism in PPAR γ2 may confer resistance to type 2 diabetes. Biochem Biophys Res Commun 2000: 271: 212-216.
20. Ek J, Andersen G, Urhammer SA et al. Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 (PPAR-γ2) gene in relation to insulin sensitivity among glucose tolerant Caucasians. Diabetologia 2001: 44: 1170-1176.
21. Akiyama TE, Nicol CJ, Fievet C et al. Peroxisome proliferator-activated receptor-α regulates lipid homeostasis, but is not associated with obesity. J Biol Chem 2001: 276: 39088-39093.
22. Eriksson JG, Forsen T, Jaddoe VWV, Osmond C, Barker DJP. The effects of childhood growth and maternal body size on insulin resistance in elderly men and women. Diabetologia 2002: 45: 342-348.
23. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972: 18: 499-502.
24. Iwata E, Matsuda H, Fukuda T et al. Mutations of the peroxisome proliferator-activated receptor γ (PPARγ) gene in a Japanese population: the Pro12Ala mutation in the PPARγ2 is associated with lower concentrations of serum total and non-HDL cholesterol. Diabetologia 2001: 44: 1354-1356.
25. Dubois M, Pattou F, Kerr-Conte J et al. Expression of peroxisome proliferator-activated receptor γ (PPARγ) in normal human pancreatic islet cells. Diabetologia 2000: 43: 1165-1169.
26. Abumrad NA, el-Maghrabi MR, Amri EZ, Lopez E, Grimaldi PA. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem 1993: 268: 17665-17668.
27. Yamamoto Y, Hirose H, Miyashita K et al. PPARγ2 gene Pro12Ala polymorphism may influence serum level of an adipocyte-derived protein, adiponectin, in the Japanese population. Metabolism 2002: 51: 1407-1409.
28. Vaccaro O, Mancini FP, Ruffa G et al. Fasting plasma free fatty acid concentrations and Pro12Ala polymorphism of the peroxisome proliferator-activated receptor (PPAR)γ2 gene in healthy individuals. Clin Endocrinol 2002: 57: 481-486.
29. Luan J, Browne PO, Harding A-H et al. Evidence for gene-nutrient interaction at the PPAR-γ locus. Diabetes 2001: 50: 686-689.
30. Lindi VI, Uusitupa MIJ, Lindström J et al. Association of the Pro12Ala polymorphism in the PPAR-γ2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study. Diabetes 2002: 51: 2581-2586.
31. Valve R, Sivenius K, Miettinen R et al. Two polymorphisms in the peroxisome proliferator-activated receptor-γ gene are associated with severe overweight among obese women. J Clin Endocrinol Metab 1999: 84: 3708-3712.
32. Le Stunff C, Fallin D, Schork NJ, Bougnères P. The insulin gene VNTR is associated with fasting insulin levels and development of juvenile obesity. Nat Genet 2000: 26: 444-446.